NCT05143307

Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

Long-Term Follow-Up Study of HIV-1 Infected Adults Exiting a Parent Study Where EBT-101 Was Administered

• Status: Enrolling By Invitation
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 9 (estimated)
• Sponsor: Excision BioTherapeutics · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).

Detailed description

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this LTFU study (EBT-101-002). All participants will have follow-up visits every six months until Year 5 post EBT-101. Thereafter, all participants will have follow-up visits annually on the anniversary of EBT-101 administration until study completion at Year 15.

Conditions

• HIV-1-infection

Interventions

Type	Name	Description
BIOLOGICAL	EBT-101	Long term follow up of participants who received EBT-101

Timeline

• Start date: 2023-07-11
• Primary completion: 2037-01-01
• Completion: 2037-04-01
• First posted: 2021-12-03
• Last updated: 2024-05-14

Locations

3 sites across 1 country: United States

Regulatory

• FDA-regulated drug study